UAE LASIK Surgery Market was valued at $17.65 Mn in 2023 and is predicted to grow at a CAGR of 6.21% from 2023 to 2030, to $ 26.91 Mn by 2030. The key drivers of this industry include rising prevalence, high disposable income, and medical tourism destinations. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
The UAE Orphan Diseases Drugs Market is projected to grow from $0.774 Bn in 2022 to $1.823 Bn by 2030, registering a CAGR of 11.30% during the forecast period of 2022 - 2030. UAE has a large patient population with rare diseases, and a growing elderly population is increasing the demand for treatments for these conditions Some of the leading players in the market include Pfizer, Sanofi, Roche, and Novartis.
US Acute Myeloid Leukemia Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. The ageing population, higher drug approval rates, the designation of acute myeloid leukaemia as an orphan disease, and rising healthcare costs are anticipated to drive the market. One of the factors accelerating the market's growth is the technological advancement made possible by the capacity to recognise damaged cells. Major global players in Acute Myeloid Leukemia Market are Ambit Biosciences Corporation, Genzyme Corporation, Celgene Corporation, Clavis Pharma ASA, Sunesis Pharmaceuticals, Cephalon, Bristol-Myers Squibb, Novartis International AG, GlaxoSmithKline.
This report presents a strategic analysis of the Egypt Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Medical and Diagnostic Laboratory Service Market, offering unmatched value, accuracy and expert insights.
Australia's healthcare diagnostic market is valued at $xx Bn in 2022 and would likely grow at a CAGR of 1.5% during 2022-2030. The Australia healthcare diagnostic market is segmented by product, end-user, and test type. The factors affecting its growth are prevalent chronic diseases, the rising geriatric population, insurance and reimbursement, and regulating bodies. Some key market players in healthcare diagnostics in Australia are Am Diagnostics, Ramsay Health Care, and Consultant Pathology Services Pty. Limited.
Bulgaria's over-the-counter (OTC) pharmaceuticals market size was valued at $137.5 Mn in 2022 and is estimated to expand at a CAGR of 6.52% from 2022 to 2030 and will reach $227.9 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.
This report presents a strategic analysis of the global clinical trials support service market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the global clinical trials support service market, offering unmatched value, accuracy, and expert insights.
By 2030, it is anticipated that the Japan Radiotherapy Market will reach a value of $711 Mn from $430 Mn in 2022, growing at a CAGR of 6.5% during 2022-30. The Radiotherapy Therapeutics Market in Japan is dominated by a few domestic players such as Hitachi, Mitsubishi Electric Corporation, and IHI Corporation. The radiotherapy market in Japan is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Japan Radiotherapy is increasing on account of the rise in cancer cases in the country.
Kenya's home healthcare market was valued at $XX Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of XX% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the aging population. The market is segmented by indication and product. Some key players in this market are On-Call Home Care, Crystal Homecare Kenya, Pro-Care Health Kenya, Go Care, Crystal Homecare, and others.
Mexico's connected healthcare market is projected to grow from $995.4 Mn in 2022 to $7469.23 Mn by 2030, registering a CAGR of 28.65% during the forecast period of 2022-30. The main factors driving the growth would be increasing technological adoption, the aging population, the rising prevalence of chronic diseases, and government support. The market is segmented by type, function, and application. Some of the major players include Okani, Prosperia, Cuentame, Medtronic, Honeywell, Siemens Healthineer, and GE Healthcare.